These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 30500082)

  • 21. [Vaccine and vaccination against poliomyelitis].
    RAMON G
    C R Hebd Seances Acad Sci; 1955 Jun; 240(24):2273-6. PubMed ID: 13240865
    [No Abstract]   [Full Text] [Related]  

  • 22. Polio eradication campaign copes with unusual outbreak.
    Willyard C
    Nat Med; 2007 Dec; 13(12):1394. PubMed ID: 18064018
    [No Abstract]   [Full Text] [Related]  

  • 23. Brain cancer vaccine looks promising in small trial.
    Hum Vaccin; 2010 Jul; 6(7):524-5. PubMed ID: 20622518
    [No Abstract]   [Full Text] [Related]  

  • 24. Dendritic cell immunotherapy for glioblastoma.
    Polyzoidis S; Ashkan K
    Expert Rev Anticancer Ther; 2014 Jul; 14(7):761-3. PubMed ID: 24850137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunotherapy for glioblastoma: the devil is in the details.
    Lesniak MS
    J Clin Oncol; 2011 Aug; 29(22):3105; author reply 3105-6. PubMed ID: 21709193
    [No Abstract]   [Full Text] [Related]  

  • 26. A new challenge for the world: the eradication of polio.
    Gentile Á; Abate H
    Arch Argent Pediatr; 2016 Dec; 114(6):557-562. PubMed ID: 27869415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Preuss Foundation Seminar on vaccine therapy for malignant primary brain tumors. February 15-17, 1998, La Jolla, Calif.
    Sampson JH
    Neuro Oncol; 1999 Jan; 1(1):33-42. PubMed ID: 11550300
    [No Abstract]   [Full Text] [Related]  

  • 28. PR1 peptide vaccine in myeloid malignancies.
    Gilbert JA
    Lancet Oncol; 2016 Dec; 17(12):e520. PubMed ID: 28100433
    [No Abstract]   [Full Text] [Related]  

  • 29. Vaccines for prophylaxis of viral infections in patients with hematological malignancies.
    Cheuk DK; Chiang AK; Lee TL; Chan GC; Ha SY
    Cochrane Database Syst Rev; 2011 Mar; (3):CD006505. PubMed ID: 21412895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Immunotherapy for brain tumor: don't get "Lost in Translation"].
    Okada H
    No Shinkei Geka; 2005 May; 33(5):433-42. PubMed ID: 15912763
    [No Abstract]   [Full Text] [Related]  

  • 31. Enhanced immunity to intracerebral breast cancer in mice immunized with a cDNA-based vaccine enriched for immunotherapeutic cells.
    Lichtor T; Glick RP; Feldman LA; Osawa G; Hardman J; O- Sullivan I; Cohen EP
    J Immunother; 2008 Jan; 31(1):18-27. PubMed ID: 18157008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early-stage progress on glioma vaccines.
    Brower V
    J Natl Cancer Inst; 2011 Sep; 103(18):1361-2. PubMed ID: 21881038
    [No Abstract]   [Full Text] [Related]  

  • 33. Vaccine therapies in malignant glioma.
    Oh T; Sayegh ET; Fakurnejad S; Oyon D; Lamano JB; DiDomenico JD; Bloch O; Parsa AT
    Curr Neurol Neurosci Rep; 2015 Jan; 15(1):508. PubMed ID: 25431096
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunotherapy of Brain Tumors.
    Dutoit V; Migliorini D; Walker PR; Dietrich PY
    Prog Tumor Res; 2015; 42():11-21. PubMed ID: 26376741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regression of orthotopic brain tumors by cytokine-assisted tumor vaccines primed in the brain.
    Tseng SH; Hsieh CL; Lin SM; Hwang LH
    Cancer Gene Ther; 1999; 6(4):302-12. PubMed ID: 10419048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase I trial of novel HER-2 vaccine for breast cancer initiated.
    Expert Rev Anticancer Ther; 2002 Oct; 2(5):483. PubMed ID: 12382513
    [No Abstract]   [Full Text] [Related]  

  • 37. Technology evaluation: Onyvax-P, Onyvax.
    Doehn C; Böhmer T; Jocham D
    Curr Opin Mol Ther; 2005 Oct; 7(5):511-9. PubMed ID: 16248287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaccine Therapy of High-Grade Gliomas.
    Ishikawa E; Muragaki Y; Yamamoto T; Ohno T; Matsumura A
    Prog Neurol Surg; 2018; 32():101-111. PubMed ID: 29990978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel Immunotherapeutics for Treatment of Glioblastoma: The Last Decade of Research.
    Khansur E; Shah AH; Lacy K; Komotar RJ
    Cancer Invest; 2019; 37(1):1-7. PubMed ID: 30632816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 19th Society for Neuro-Oncology Annual Meeting.
    Collingridge D
    Lancet Oncol; 2015 Jan; 16(1):18. PubMed ID: 25638541
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.